Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-107,119
Closed -$64.8K 3332
2025
Q1
$64.8K Hold
107,119
﹤0.01% 3250
2024
Q4
$47.5K Hold
107,119
﹤0.01% 3316
2024
Q3
$109K Hold
107,119
﹤0.01% 3301
2024
Q2
$118K Buy
+107,119
New +$237K ﹤0.01% 3298
2023
Q2
Sell
-203,878
Closed -$244K 3251
2023
Q1
$244K Buy
203,878
+5,440
+3% +$9.93K ﹤0.01% 2953
2022
Q4
$298K Sell
198,438
-31,566
-14% -$87.8K ﹤0.01% 2988
2022
Q3
$720K Sell
230,004
-20,592
-8% -$82.2K ﹤0.01% 2869
2022
Q2
$8.59M Buy
250,596
+124,543
+99% +$390K ﹤0.01% 1613
2022
Q1
$4.32M Buy
126,053
+57,407
+84% +$351K ﹤0.01% 2141
2021
Q4
$2.35M Sell
68,646
-4,651
-6% -$121K ﹤0.01% 2492
2021
Q3
$3.1M Buy
+73,297
New +$2.72M ﹤0.01% 2459

Other funds holding IVVD

Nuveen's IVVD Position: Q2 2025 in Review

Nuveen sold out of Invivyd (IVVD) in Q2 2025, closing a stake of 107,119 shares — an estimated $64.8K sold.

Nuveen first reported a position in IVVD in Q3 2021 and held it in 11 quarters. The position peaked at $8.59M in Q2 2022. 68 funds tracked by Wall St. Rank hold IVVD as of Q2 2025.

  • Nuveen reported no remaining Invivyd position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 107,119 Invivyd shares in Q2 2025, an estimated $64.8K.
  • Nuveen first reported a position in Invivyd in Q3 2021 and held it in 11 quarters.
  • Nuveen's Invivyd position peaked at $8.59M in Q2 2022.
  • 68 funds tracked by Wall St. Rank held Invivyd as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.